2008

2010

8. juni 2010:Pressemeddelelse nr. 5, 2010: Zealand Pharma Announces An Extension of The Lixisenatide...

Read More >
Meet us

The 31st European Peptide Symposium, Copenhagen, Denmark, 5-9 September 2010 (Science) 46th An...

Read More >

2008

27 November 2008:
Announcement no. 3, 2008: Zealand Pharma and Helsinn Healthcare Sign a Partnering Agreement for ZP1846, a novel GLP-2 agonist

28 August 2008:
Announcement no. 2, 2008: Zealand Pharma today announced that Dr. David H Solomon has been appointed Chief Executive Officer

12 February 2008:
Press release no. 1, 2008: Phase III program for AVE0010/ZP10 licensed from Zealand Pharma A/S will begin in the first quarter of 2008

Tip a friend

Fill in the form below to tip a friend about this page.

Subscribe

When this page is updated you will be updated by e-mail.

Related links

Home Legal Disclaimer Updated: 27.7.2010